Vicore Pharma Hldg AB (VCRE) Stock Price, News & Analysis
Company Description
Vicore Pharma Hldg AB (NASDAQ: VCRE) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $320.7M, ranking #4,127 among all listed U.S. companies by market cap.
VCRE has declined 29.9% over the past year, placing it at #3,299 in year-to-date performance among tracked companies. Shares last traded at $11.38.
This page collects what Stock Titan holds for VCRE, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Vicore Pharma Hldg AB (VCRE) stock last traded at $11.38, down 0.35% from the previous close. Over the past 12 months, the stock has lost 29.9%. At a market capitalization of $320.7M, VCRE is classified as a small-cap stock with approximately 28.2M shares outstanding.
VCRE Rankings
Latest News
Vicore Pharma Hldg AB has 2 recent news articles. Of the recent coverage, 0 articles coincided with positive price movement and 1 with negative movement. View all VCRE news →
SEC Filings
Vicore Pharma Hldg AB has filed 1 recent SEC filing, including 1 Form 6-K. The most recent filing was submitted on July 6, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all VCRE SEC filings →
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
VCRE Company Profile & Sector Positioning
Vicore Pharma Hldg AB (VCRE) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ. In monthly performance, the stock ranks #3,731 among all tracked companies.